Drug
Ldv Sof
Ldv Sof: highest development phase Phase 3, developed by Gilead Sciences. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| LDV/SOF NCT02472886 | Phase 3 | Hepatitis C Virus Infection |
| LDV/SOF NCT02457611 | Phase 2 | Hepatitis C Infection With HIV Co-Infection |
| LDV/SOF NCT01726517 | Phase 2 | Chronic Hepatitis C Virus |
Latest
No recent events.
Follow Ldv Sof on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.